SRI spins off pharmaceutical development | Chemical & Engineering News
Volume 82 Issue 23 | p. 12 | Concentrates
Issue Date: June 7, 2004

SRI spins off pharmaceutical development

Department: Business

SRI International has spun off Bridge Pharmaceuticals, a drug development services group that works with laboratories in Asia to serve the U.S. and European markets. Bridge raised $3.5 million in an investment round led by WI Harper Group. The company will continue to work in partnership with SRI's PharmaStart initiative, a consortium including four California universities aimed at expediting the development of university-based drug research. Bridge has licensed from SRI three late-stage preclinical drugs for cancer treatment.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment